A B S T R A C T The association of transferrin receptor expression with cellular proliferation has been studied extensively, but a number of events have not been defined. We therefore assayed receptor on promyelocytic leukemia (HL-60) cells at early times after exposure to a stimulus for proliferation (subculture), as well as agents that either induce differentiation (dimethylsulfoxide [DMSO]) or inhibit iron uptake (transferrin-gallium). Within 4 h after subculture, we found that a significant increase in total cellular immunoreactive receptor occurred that preceded by 8 h the increase in cell-surface transferrin binding. Automated fluorocytometric analysis of cells in an immunofluorescent assay indicated that increased surface receptor density appeared on cells in the S, G2, and M phases of the cell cycle. DMSO-treated cells proliferated at the same rate as untreated (control) cells for the first 72 h, but as early as 12 h after treatment transferrin receptor was significantly decreased (65% of control cells). Further decreases occurred at later time points until transferrin receptor was undetectable after 7 d, when proliferation had ceased, cells were arrested in G1 phase of the cell cycle, and myeloid differentiation occurred. After exposure to transferrin-gallium, proliferation ceased, but cells exhibited increased surface receptor and were arrested at S phase of the cell cycle without associated myeloid differentiation.
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We conclude that events preceding cell division provide the regulatory stimulus for the synthesis and subsequent appearance of the transferrin receptor on the cell surface. Additionally, decreased receptor expression may be important in causing cessation of prolif-
INTRODUCTION
Cell surface receptors for transferrin, the major plasma iron transport protein (1), were initially characterized on cells with high iron requirements including hemoglobin-producing cells and placental cells (2) (3) (4) (5) (6) . More recently, the finding of high densities of transferrin receptors on cells that would appear to require less iron, including proliferating nonhemoglobin-producing cells (7) (8) (9) , has generated considerable interest. These studies have indicated that transferrin-binding sites markedly increase soon after these cells are exposed to tissue culture conditions that stimulate proliferation (7, 8, 10, 11) . Furthermore, studies using immunoassay techniques as well as transferrin binding studies have indicated that this increase in transferrin binding is due to an actual increase in total cellular immunoreactive receptor molecules, and is not due to a change in receptor affinity for transferrin or receptor availability (12, 13) . These findings may have functional significance, since previous studies have demonstrated that the addition of transferrin to serum-free media is a requirement for cell growth (14) (15) (16) , and an important recent study has indicated that a specific monoclonal antibody that blocks transferrin binding causes arrest of cellular proliferation (17) .
Nevertheless, although these previous studies have suggested that the presence of the transferrin receptor represents a marker for proliferation and that it prob-ably has functional importance, extensive studies have not been performed to determine the early events associated with expression of the receptor on actively proliferating cells, nor has receptor density on subpopulations of cells in different phases of the cell cycle been measured. These studies are important, since they may not only further elucidate the functional requirements for transferrin binding during proliferation, but they may also better define the role that variation in expression of transferrin receptor on the cell plays in the regulation of proliferation. Additionally, since recent in vitro studies indicate that induction of cell differentiation may initially require decreased cellular proliferation (18) , studies of regulation of transferrin receptor density soon after exposure to an inducer of differentiation may indicate whether receptor expression plays a role in this process.
We have, therefore, studied the well-described human promyelocytic leukemic cell line (HL-60) (19) at various stages of cellular proliferation and during dimethylsulfoxide (DMSO)l induction of differentiation (20, 21) , in order to measure changes in transferrin receptor by immunoassay techniques and transferrinbinding studies. Our studies indicate that events preceding cell division provide the regulatory stimulus for the synthesis and subsequent appearance of the transferrin receptor on the cell surface. The peak of surface receptor density appears on cells at a stage that occurs just before cell division. We also show that relative transferrin receptor density decreases at a very early stage after induction of differentiation, even before proliferation has decreased and subsequent differentiation occurs. These latter changes, however, appear to be somewhat different from the events associated with the addition of specific agents that block either transferrin-mediated iron uptake (i.e., gallium salts or transferrin-gallium) or transferrin binding (i.e., monoclonal antibodies) and inhibit cellular proliferation resulting in arrest of cells at a diffent phase of the cell cycle without induction of myeloid differentiation.
METHODS
Human apotransferrin, nitroblue tetrazolium (NBT) and DMSO with nonradioactive iron or gallium (23) , respectively. A similar method was used for saturation of apotransferrin with 59Fe (12) . Iodination of transferrin-_9Fe and the human transferrin receptor was performed by previously described methods (12) .
The HL-60 (human promyelocytic leukemia) cells were obtained from the laboratory of Dr. Michael Glode, University of Colorado Medical School. Cells were grown in RPMI 1640 medium (M. A. Bioproducts, Walkersville, MD) containing 10% fetal calf serum in a 7.5% CO2 atmosphere. For all experiments, cells grown to confluence were subcultured at a density of 5 X 105/ml and reached a maximum density (confluence) of -2.2 X 106 cells/ml in 72 h. This rate of proliferation is similar to that reported recently by others (24) . Studies using DMSO were carried out by plating cells in a manner identical to that described above, except that DMSO was added to the media. Cells with normal growth kinetics in serum-supplemented media reached confluence at 72 h and maintained >95% viability over the next 24 h, but significant cell death occurred after this period. Therefore, cells were seldom exposed continuously to the different agents for longer than 3 d, and unless specifically stated they were recultured at 3-d intervals at a concentration of 5 X 105 cells/ml in fresh media containing the different agents until a desired time of exposure had been reached. Aliquots of cells at different time points (after subculture in fresh media) were removed for assays and transferred to 15-ml polystyrene tubes and centrifuged at 200 g for 10 min in a Beckman TJ-6 centrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, CA). The supernatant was aspirated and the pellet resuspended in ice-cold 10 mM KPO4, pH 7.5, 150 mM NaCl (PBS) and bovine serum albumin (BSA), 1 mg/ml. All cell counts were performed in triplicate with a hemacytometer.
Transferrin-binding studies were performed by incubating varying concentrations of 1251-transferrin-59Fe (5, 000 1251 cpm/mg protein) with 0.5 X 106 cells in a total incubation volume of 500 ,ul PBS and 1 mg/ml BSA. Incubations were carried out for 4 h at 4°C. The incubations for binding studies were performed at 4°C to insure that internalization of radioactive transferrin was not included in the calculations (25, 26) . The 4-h incubation period was chosen, since binding of 125I-transferrin to the cells had reached saturation by this time. After the incubation, 1 ml of ice-cold PBS with BSA was added to each tube and after centrifugation at 500 g at 40C, the supernatant was aspirated, and the pellet was counted for radioactivity. Specific binding was determined by subtracting the radioactivity in an identical sample that contained 1,000-fold excess of nonradioactive transferrin. The results were plotted and maximal transferrin binding was calculated according to the method of Scatchard (27) .
Total cellular immunoreactive transferrin receptor protein was determined in a double-antibody precipitation radioimmunoassay as previously described (12 For studies using varying concentrations of apotransferrin and other forms of transferrin (see above), we used serumfree media supplemented with various concentrations of transferrin and 5 jig/ml of insulin (defined media), which has been noted to support growth of HL-60 cells (16) . Although cell proliferation in defined media was somewhat slower than in serum-supplemented media, there was a preLeukemic Cell Transferrin Receptor dictable rate of cell growth similar to the rate previously described (16) . Moreover, as reported (16) , cells exposed to DMSO in defined media also exhibited myeloid differentiation. Serum-free media lacking either transferrin, insulin, or both failed to support cell growth and rio effect on cellular differentiation was noted.
Cell proliferation was assessed by performing cell couints, as well as bv analyzing DNA distribution (see below). Differentiation of a population of cells was assessed using NBT reduction (24, 28) , as well as morphologic criteria to identify metamyelocytes and more mature cells (20) .
Cell surface transferrin receptor was assayed by a doubleantibody immunofluorescence technique (12, 29) . Approximately 1-3 million HL-60 cells were washed with ice-cold PBS, resuspended in 100,ul of PBS, and first incubated with 100 Al of polyclonal rabbit anti-human transferrin receptor antisera (6) at 4°C for 1 h. The cells were then washed by centrifugation to remove unbound antibody and resuspended in 100 Al of PBS followed by the addition of 100 1 l of the second antibody, goat anti-rabbit IgG labeled with fluorescein isothiocyanate (Gibco Laboratories, Grand Island, NY) with the second incubation performed at 4°C for 1 h. Some cell populations were analyzed separately for cellular DNA by the propidium iodide staining technique (30) . For this technique, cells were fixed in 70% ethanol and washed with PBS; then the cell pellet was resuspended in RNase (Sigma Chemical Co.) (1 mg/ml) and incubated for 30 min at 37°C. After this, the cells were again washed twice and resuspended in 1 ml of propidium iodide (10 mg/ml in PBS) for 20-30 min at 4°C.
For some experiments, the same cells were stained for both immunofluorescent cell surface transferrin receptor and cellular DNA. After immunofluorescent staining as described above, cells were fixed by a 10-s exposure to 1% paraformaldehyde, immediately diluted 1:5 with PBS and then washed twice by centrifugation at 4°C. Cells were then resuspended in 1 ml of RNase and incubated at 4°C for 1 h, washed free of RNase, and stained with propidium iodide as described above.
Samples of cells were then run through a fluorescenceactivated cell sorter, the FACS IV flow cytometer (BectonDickinson FACS Systems, Sunnyvale, CA), with a 50-ym nozzle tip. An argon-ion laser operating at 488 nm with a 5-W intensity was used as an excitatioin source. Red fluorescence (DNA stain) and green fluorescence (surface receptor immunofluorescence) were detected at 550-590 and 510-520 nm, respectively. In the experiments shown (Figs. 2-4), -25,000 cells were analyzed for each cell sample. Although a previous study had indicated that changes in cell surface area during cellular proliferation do rnot appreciably affect calculation of binding sites expressed per cell (31), each cell sample was analyzed for forwvard-scatter distribution and the integrated cturve (histogram) obtained was an indicator of cell volume (30) , so that wc also could estimate surface area (29) . Simultaneously, another histogram plotted fluorescence intensity on the x-axis vs. the nuimber of cells with a given fluorescenit intensity on the y-axis. For immunofluorescence studies defining suirface transferrin receptor (green fluorescence), an automated analysis of each cell population calculated a point on the x-axis that represented the rnedian immunofluorescence intenisity (MIT) of the cell population. This point couldl not be assigned a specific unit quantity, but when two samples (one heing a control sample) were analyzed at the same time, the test sample could be expressed as a percentage of control. This anialysis was possible, since utnder rno: t conditiorns described ibove, ineludineg cnfluent cells, e nough surfarce t ransferrin rr-ceptor was expressed so that the specific immunofluorescent polyclonal antibody technique was sensitive enough to detect >90% of cells as fluorescent positive when compared with fluorescence detected when control rabbit serum was substituted for antitransferrin receptor antibody as the first antibody.
When >10% of cells were immunofluorescent negative, such as with continued DMSO exposure, calculation of MII could be assigned a percentage of control expressed as the maximum value possible (e.g., <20% of control). Measurement of surface transferrin receptor by this method was useful, since only a few cells were needed for an accurate analysis and, if appropriate controls were analyzed at the same time, a large number of samples could be studied. Moreover, as with measurements we have previously described (12, 29) while studying the above cell system, the presence of transferrin bound to receptor or the addition of 50 Mg human transferrin to the incubation mixture had no effect on fluorescence intensity. Thus, this method was particularly useful in measuring surface transferrin receptor under conditions in which varying concentrations and forms of transferrin were added to the cells in culture.
When samples were analyzed for DNA content, histograms represented the red fluorescence intensity (DNA content) on the x-axis and the number of cells with certain red fluorescence intensity on the y-axis. Automated analysis of subpopulations of cells with differences in DNA content permitted calculation of percentages of cells in GC, S, or G2 and M phases of the cell cycle. Although the automated technique could not separate cells in either G2 or M phases of the cell cycle, when a number of samples were analyzed morphologically, it was found that even at the 24-h point after subculture, when the greatest percentage of cells were in the active phases of proliferation, the cells that were morphologically in mitosis represented only about one-third of cells in G2 and M and -8% of the total cell population, which as a mitotic index agrees with studies performed by others (24) .
In certain samples that had been stained for both immunofluorescent surface receptor and cellular DNA, two histograms were obtained simultaneously, one representing DNA distribution and another representing surface receptor fluorescence. Cells in different phases of the cell cycle (as evidenced by different amounts of DNA) were studied by using the capabilities of the FACS IV to gate a desired subpopulation of cells. The corresponding median intensity of surface fluorescence could then be determined for that particular subpopulation of cells (GC, S, or G2 and M).
Cells fixed and stained for DNA after immunofluorescent surface receptor staining showed a slight increase in green fluorescent-negative cells (-15%) as compared with cells stained for immunofluorescent receptor alone. We surmised that these negative cells had been randomly damaged by the fixation process, since, when these cells were discounted, the histogram obtained showed an identical intensity of surface fluorescence as cells stained for immunofluorescence alone.
Therefore, it appeared that the DNA staining per se did not alter surface receptor fluorescent intensity.
RESULTS
We had previously shown that actively proliferating cells have higher numbers of both transferrin-binding sites and total cellular immunoreactive transferrin receptor than nonproliferating or confluent cells (12 The delay in the expression of newly synthesized transferrin receptor on the cell surface agrees with previous synthetic studies (32) , which demonstrated rapid synthesis of an immature molecule, which was converted a number of hours later into the mature receptor protein.
According to previously defined calculations (12) , the data shown in Fig. 1 A indicate that transferrin-binding sites increase from 26,000 sites/cell in confluent cells to 114,000 sites/cell at maximal transferrin binding at 24 h, whereas total cellular immunoreactive receptor molecules increase from 214,000 molecules/cell at confluence to 1,660,000 molecules/cell at the highest density of receptor. HL-60 cells cultured in 1.25% DMSO exhibit an early decrease in cellular proliferation, followed by differentiation of cells to more mature myeloid forms (20) . In addition to these effects, we found that cells exposed to 1.25% DMSO, in agreement with other studies (21, 33) , showed an associated decrease in surface transferrin receptor. Moreover, when cells were exposed to only 1% DMSO, there was a clear dissociation between relative decreases in transferrin receptor density and decreased cellular proliferation (Fig. 1 B) . Despite an identical rate of proliferation compared with control cells for the first 72 h (see below), DMSOtreated cells did not show the expected increase in transferrin receptor during active cellular proliferation. Thus, although a small increase in both immunoreactive transferrin receptor and transferrin binding is noted in treated cells at 12 h after subculture, this increase is significantly lower than that seen with untreated cells at the same time point. Furthermore, whereas control cells show even further increases in both immunoreactive transferrin receptor and maximal transferrin binding at 24 h, DMSO-treated cells showed a plateau in both values (Fig. 1 B) , even though proliferation continued at the same rate. A decreased affinity of transferrin binding to the cell surface receptor does not appear to be a significant factor, since Scatchard analysis of transferrin binding to control cells and DMSO-treated cells at different time points resulted in similar association constants (Ka = 2-5 x 108 M-1).
To obtain a better definition of the effect of proliferation and DMSO treatment on transferrin receptor density, we measured surface transferrin receptor using the immunofluorescence technique and an automated fluorocytometer. The results of these analyses on both control and DMSO-treated cells at various time points after subculture are shown in Fig. 2 Fig. 2 , the histograms obtained for control cells by the immunofluorescence technique as a measure of immunoreactive surface transferrin receptor first showed a significant increase in MIT (measured as a shift to the right in the relative scale shown on the x-axis) at 12 h after subculture, a result that agrees with measurements of surface transferrin receptor expressed as maximal transferrin binding (Fig. 1 A) . Also as seen with measurements of 'maximal transferrin binding, the peak increase in mean cellular surface transferrin receptor by the immunofluorescence technique is seen at 24 h. At 48 h, there is a decrease in the MIT, which decreases even further to base line at 72 h, when the cells become confluent.
Forward scatter determinations, which are representative of cell volume (34, 35) not account for the marked increase in transferrin receptor seen during proliferation. As expected, cells cultured in 1% DMSO as compared with control cells showed a much lower median intensity of immunofluorescence at all time points starting at 12 h after subculture (Fig. 2) . MII of treated cells at 24 and 48 h was 35 and 38% of control values, respectively, a result that agrees well with comparison of maximal transferrin binding between the two groups of cells (Fig. 1) . At all time points, forward scatter histograms showed essentially identical patterns as control cells (data not shown). At 72 h, DMSOtreated cells become confluent, but, using the automated immunofluorescence assay, we found that these confluent cells had decreased immunofluorescence compared with control cells, with the median fluorescence somewhat <40% of control, since -15% of cells exhibited negative fluorescence.
We suspected that subpopulations of cells with high surface transferrin receptor might represent cells in the active phases of the cell cycle, since these highly fluorescent cells were seen at time points preceding and during active proliferation (Fig. 2) . Fig. 3 As shown in Fig. 3 B , analyses of the cell population cultured in DMSO for 24 h showed a marked decrease in surface transferrin receptor. However, analyses of subpopulations of cells in different phases of the cell cycle, although MII was always lower than the control cell sample, still showed that treated cells in active stages of proliferation had higher densities of surface transferrin receptor as compared with cells in GI phase.
To study further the effect of DMSO, we analyzed the DMSO-treated cells grown beyond 72 h. Previous studies have exposed cells to DMSO continuously for up to 6 d without subculture. However, to assess the prolonged effect of DMSO on transferrin receptor density and resultant decreases in cellular proliferation, cells continuously exposed to 1% DMSO were subcultured in fresh media every 3 d at lower density (5 X 105 cells/ml) to stimulate proliferation (Table I) . Although 1% DMSO-treated cells proliferated at the same rate as control cells for the first 72 h (Fig. 2) , when the treated cells were recultured, a definite decrease in the rate of proliferation was noted during the next 3 d (days 4-6 of DMSO exposure), as compared with control cells, which always proliferated at the same rate (Fig. 2) . Not only is the cell number less at days 4, 5, and 6, the percentage of cells in GI at these time points also is greater, indicating that fewer cells are entering the active phases of the cell cycle. Significantly, the surface transferrin receptor on these recultured cells decreases even further when compared with control cells (Table I) Table I , significant differentiation occurs beginning at day 4 after recultured cells are exposed to DMSO. The degree of differentiation correlates directly with the decrease in proliferation and is coincidental with the loss of transferrin receptor.
Our results suggested that the attenuation of transferrin receptor density with DMSO treatment results in eventual arrest of cellular proliferation with associated myeloid differentiation. We therefore attempted to determine the effect of other agents that might specifically affect transferrin receptor density and result in either arrested proliferation and/or differentiation. One such agent chosen was gallium, a relatively nontoxic metallic cation that avidly binds to transferrin (23) . Previous studies have indicated that gallium salts inhibited growth of some cells in tissue culture (36, 37) , and we also found that the addition of various concentrations of gallium nitrate to HL-60 cells resulted in a dose-related inhibition of proliferation. For example, a concentration of 9 jig/ml of gallium in serum-supplemented media resulted in cessation of proliferation 2 d after subculture with >95% of cells still viable. However, for better control of the amount of gallium and transferrin present, cells were cultured in serum-free media with different forms of transferrin. When transferrin-iron was added at a concentration of either 25 jg/ml (Table II) or up to 150 jg/ml (data not shown), the rate of proliferation was identical to that seen with 25 jig/ml apotransferrin (16; see Methods). When cells exposed to the different forms of transferrin in serum-free media were analyzed for transferrin receptor in the automated immunofluorescence assay, there was, as expected, a threefold increase in Mll at day 1 after subculture as compared with confluent cells. Moreover, in this sensitive assay, transferrin receptor expression showed a slight down-regulation in transferrin-iron-supplemented cells as compared with apotransferrin-supplemented cells for each day after subculture (Table II) , in spite of the same rate of proliferation. As with gallium nitrate, the addition of transferrin-gallium to the serum-free media resulted in a dose-related decrease in proliferation (Table II) . Thus, when 150 gg/ml of transferrin-gallium was added to the media (0.25 jg/ ml gallium), cells ceased proliferation by day 2 after subculture. It was noteworthy that cells supplemented with transferrin-gallium showed a significant up-regulation in surface transferrin receptor (Table II) , in spite of decreased proliferation. Furthermore, DNA analyses of cells exposed to transferrin-gallium (Table   II , Fig. 4 ) showed a decrease of cells in the GI phase of the cell cycle and indicated there was arrest of cells in the S phase, and to a lesser extent G2 and M phases. Exposure of cells to a lower dose of transferrin-gallium (25 Mg/ml) also led to eventual growth arrest, but only after the cells have been replated in fresh media after the first 72 h and continuously exposed to the transferrin-gallium for 6 d (Table II) . Again, analyses of surface transferrin receptor showed up-regulation of receptor compared with the base-line values obtained with addition of apotransferrin. This up-regulation increased even further as proliferation decreased. Additionally, although DNA analyses for the first 3 d of exposure to the low dose gallium was similar to that seen with transferrin-iron additions, when proliferation decreased at later time points, arrest of cells in the S phase of the cell cycle became evident (Fig.  4) . Significantly, when growth was arrested with either dose of transferrin-gallium, there was no increase in cellular differentiation as compared with control cells. Thus, as opposed to treatment with DMSO, inhibition of cellular proliferation with transferrin-gallium results in no significant myeloid differentiation and is associated with arrest of cells in the S phase of the cell cycle.
It is of interest that the effect of gallium on cellular proliferation is similar to the effect caused by inhibi- 4) .0 E (24) . Since it is not known how the increase in density in transferrin receptor functions as an event leading to cell division, we studied several agents that might modulate transferrin receptor density. The first agent chosen, DMSO, has been studied extensively in the HL-60 cell system, and although the mechanism of action has not been elucidated, cells exposed to DMSO show decreased proliferation followed by terminal myeloid differentiation. Although previous reports have indicated that surface transferrin receptor density on HL-60 cells decreases during DMSO treatment (21, 33) and that this decrease may precede by 24 In additional experiments, we studied the effect of agents that we hypothesized would be more specific in affecting transferrin receptor expression. Previous studies have shown that radioactive gallium was taken up avidly by certain tumors (41) , and the use of gallium salts as an antitumor agent had been suggested a number of years ago (42) . More recent studies suggest that the addition of transferrin potentiates gallium salt-mediated arrest of cellular proliferation (36) , an effect that may be related to inhibition of iron uptake (37) . We used a well controlled serum-free system to demonstrate that cells exposed to transferrin-gallium showed a dose-related decrease in cellular proliferation and an associated up-regulation of surface transferrin receptor. The fact that this effect can be inhibited by either the addition of transferrin-iron or iron salts to the media adds further proof that increased transferrin receptor density during proliferation functions to provide iron to proliferating cells.4 Thus, our experiments showing similar rates of proliferation using either apotransferrin or transferrin-iron may be deceiving, since iron present even in trace amounts in media may be enough to support a kinetically active iron pool necessary for cell division. The effect of gal4Chitambar, C. R., and P. A. Seligman. Unpublished observations. lium on arrested proliferation, can be distinguished from the DMSO effect by at least two aspects: (a) Transferrin-gallium treatment is associated with an increase in transferrin receptor density suggesting upregulation of receptor, whereas DMSO treatment results in decreased transferrin receptor. (b) Arrested proliferation with DMSO results in accumulation of cells in the GC phase of the cell cycle, whereas transferrin-gallium, as with our preliminary study using blocking monoclonal antibody and the studies of others (17) , results in arrest of cells in active phases of the cell cycle (particularly S phase). This latter effect may be related to the fact that DMSO-treated cells precede through the stages of myeloid differentiation and gallium-treated cells do not show significant increases in differentiation even though growth arrest occurs. Thus, although there is some controversy as to whether differentiation is linked to cessation of proliferation and arrest of cells in a specific phase of the cell cycle (24, 43) , the above data support the recent hypotheses that cells must be arrested in a specific stage of GI to differentiate (18) . These data additionally indicate that, although modulation of receptor density, with agents such as DMSO or phorbol esters (44) , may be associated with differentiation, the specifics of this association are presently unknown.
It appears, therefore, that the modulation of transferrin receptor associated with DMSO exposure is associated with other events besides simply an inhibition of iron uptake or transferrin binding to cells, since arrest of cells occurs at a different stage in the cell cycle and differentiation begins. However, it is also clear that agents that affect iron uptake may be useful in further studies to better define cellular proliferation and additionally may be useful as chemotherapeutic agents. Significantly, since our in vitro studies show that transferrin-gallium results in marked inhibition of cellular proliferation, reevaluation of the use of gallium salts as a chemotherapeutic modality should recognize gallium interactions with transferrin, as has been suggested by clinical studies at other institutions (45) .
